BAQSIMI ONE PACK
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 18 Mar 2026)
What this means for you
Registered since 24 Nov 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88173308
- Registration number
- 6206298
- Mark type
- Stylized text
- Filed
- 29 Oct 2018
- Published for opposition
- 05 Mar 2019
- Registered
- 24 Nov 2020
- Attorney of record
- Alyssa M. Worsham
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, glucagon for diabetes related hypoglycemia, including low blood sugar, diabetes insulin shock, and insulin reaction
Owner
- AMPHASTAR PHARMACEUTICALS, INC., RANCHO CUCAMONGA, CA, US
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 18 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 18 Mar 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Dec 2025 — TEAS SECTION 8 & 15 RECEIVED
- 24 Nov 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Sept 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Sept 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Sept 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Sept 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Sept 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Aug 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 23 Oct 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Oct 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Oct 2020 — STATEMENT OF USE PROCESSING COMPLETE